Vaccines (Feb 2023)

B-Cell Epitope Mapping of the <i>Plasmodium falciparum</i> Malaria Vaccine Candidate GMZ2.6c in a Naturally Exposed Population of the Brazilian Amazon

  • Barbara de Oliveira Baptista,
  • Ana Beatriz Lopes de Souza,
  • Luana Santos de Oliveira,
  • Hugo Amorim dos Santos de Souza,
  • Jenifer Peixoto de Barros,
  • Lucas Tavares de Queiroz,
  • Rodrigo Medeiros de Souza,
  • Linda Eva Amoah,
  • Susheel Kumar Singh,
  • Michael Theisen,
  • Rodrigo Nunes Rodrigues-da-Silva,
  • Evelyn Kety Pratt Riccio,
  • Paulo Renato Rivas Totino,
  • Josué da Costa Lima-Junior,
  • Cláudio Tadeu Daniel-Ribeiro,
  • Lilian Rose Pratt-Riccio

DOI
https://doi.org/10.3390/vaccines11020446
Journal volume & issue
Vol. 11, no. 2
p. 446

Abstract

Read online

The GMZ2.6c malaria vaccine candidate is a multi-stage P. falciparum chimeric protein that contains a fragment of the sexual-stage Pfs48/45-6C protein genetically fused to GMZ2, an asexual-stage vaccine construction consisting of the N-terminal region of the glutamate-rich protein (GLURP) and the C-terminal region of the merozoite surface protein-3 (MSP-3). Previous studies showed that GMZ2.6c is widely recognized by antibodies from Brazilian exposed individuals and that its components are immunogenic in natural infection by P. falciparum. In addition, anti-GMZ2.6c antibodies increase with exposure to infection and may contribute to parasite immunity. Therefore, identifying epitopes of proteins recognized by antibodies may be an important tool for understanding protective immunity. Herein, we identify and validate the B-cell epitopes of GMZ2.6c as immunogenic and immunodominant in individuals exposed to malaria living in endemic areas of the Brazilian Amazon. Specific IgG antibodies and subclasses against MSP-3, GLURP, and Pfs48/45 epitopes were detected by ELISA using synthetic peptides corresponding to B-cell epitopes previously described for MSP-3 and GLURP or identified by BepiPred for Pfs48/45. The results showed that the immunodominant epitopes were P11 from GLURP and MSP-3c and DG210 from MSP-3. The IgG1 and IgG3 subclasses were preferentially induced against these epitopes, supporting previous studies that these proteins are targets for cytophilic antibodies, important for the acquisition of protective immunity. Most individuals presented detectable IgG antibodies against Pfs48/45a and/or Pfs48/45b, validating the prediction of linear B-cell epitopes. The higher frequency and antibody levels against different epitopes from GLURP, MSP-3, and Pfs48/45 provide additional information that may suggest the relevance of GMZ2.6c as a multi-stage malaria vaccine candidate.

Keywords